FDA says single-dose shot from J&J prevents severe COVID
/// From: Johnson, Linda <email@example.com> Date: Thursday, November 12, 2020 at 4:59 PM To: PHO - AP Headquarters Photo Desk <firstname.lastname@example.org> Subject: JJ Vaccine Administration Photos -- Need someone to prep Folks, I have been asking companies developing coronavirus vaccines for more file shots. These six show showing administration of the vaccine. I just sent you eight other photos showing laboratory research, etc. I have obtained one photo release from Johnson Johnson that is to cover all 14 photos and will send that in a minute. The media rep I'm working with does not have the dates these were taken, so I'd like to see if you folks can decide which ones you like the best and then tell me and I can go back to the media rep and get when and where they were shot and something about what's happening in the photo for the caption. Thanks! Linda Linda Johnson Medical/Pharmaceuticals/Biotech Writer Associated Press Trenton, NJ 609-392-0657 (direct) 609-392-3622 (Trenton bureau) email@example.com From: Sargent, Jake [JJCUS] <JSargen3@ITS.JNJ.com> Sent: Thursday, November 12, 2020 3:30 PM To: Johnson, Linda <firstname.lastname@example.org> Subject: JJ Vaccine Photos [EXTERNAL]
Posted at 5:23 AM, Feb 24, 2021
and last updated 2021-02-24 17:13:06-05
ASSOCIATED PRESS —WASHINGTON (AP) — An analysis by U.S. regulators says Johnson & Johnson's single-dose vaccine provides strong protection against severe COVID-19. The report Wednesday confirmed that overall the vaccine is about 66% effective at preventing moderate to severe COVID-19. On Friday, a panel of experts to the Food and Drug Administration will debate if the evidence is strong enough to recommend the long-anticipated shot. The FDA is expected to make a final decision within days. If the FDA clears the J&J shot for U.S. use, it won’t boost vaccine supplies significantly right away. Only a few million doses are expected to be ready for shipping in the first week.
Copyright 2021 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed without permission.